Skip to content
DataLookout
Menu

NCT03723564

Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia

StatusRecruiting
PhasePhase 1
Primary completion (estimated)

At risk: Primary completion moved 2 years later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 11 versions: 9 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Dec 31, 2026 to Dec 31, 2028
    • Eligibility criteria expanded, about 17 words
    • Study completion pushed from Dec 31, 2027 to Dec 31, 2029
    • Study description revised
  2. Notable Primary completion date: Dec 31, 2025 to Dec 31, 2026
    • Study completion date: Dec 31, 2026 to Dec 31, 2027
    • Site contact updated
    v10
  3. Minor Site contact updatedv9
  4. Notable Primary completion date: Dec 31, 2023 to Dec 31, 2025
    • Study completion date: Dec 31, 2025 to Dec 31, 2026
    • Site contact updated
    v8
  5. Notable Primary completion date: Dec 31, 2022 to Dec 31, 2023
    • Study completion date: Dec 31, 2024 to Dec 31, 2025
    • Site contact updated
    v7
Show 3 earlier versionsHide 3 earlier versions
  1. Notable Lead sponsor: Rodrigo Ruano M.D., Ph.D to Mayo Clinic
    • Site contact updated
    v5
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Nov 1, 2018 to Oct 1, 2018
    v3
  3. Notable Primary endpoints: 3 to 1
    • Secondary endpoints: 1 to 2
    v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Adverse Events
Timeframe: First amnioinfusion through delivery which may be up to 22 weeks.

Secondary (2)

Survival to renal transplant
Survival to dialysis

Arms and interventions

AmnioinfusionExperimental

Lactated Ringers Solution for Injection --- Serial ultrasound-guided amnioinfusion procedures will be performed on fetuses having severe LUTO or bilateral renal agenesis that are diagnosed between 18 0/7-25 6/7 weeks.

Drugs: Lactated Ringers Solution for Injection

Sites

1 site in 1 country

  • Mayo ClinicRochester, Minnesota, United States